We demonstrated that DDX17 augmented CRC cell metastasis and EMT progression via downregulation of miR-149-3p, which resulted in increased CYBRD1 level by decreased binding to the 3′-UTR of CYBRD1 mRNA (Fig. 7). Here, DDX17 is linked to colorectal carcinoma.